Biohaven (BHVN) Change in Cash (2021 - 2026)
Biohaven's (BHVN) quarterly Change in Cash came in at $44.3 million in Q1 2026, up 30053.74% year-on-year from N/an in Q1 2025, and little changed quarter-over-quarter from $44.4 million in Q4 2025.
Biohaven (BHVN) Change in Cash (2021 - 2026) Analysis & Trends
Biohaven has disclosed Change in Cash across 6 years of filings, most recently posting $44.3 million for Q1 2026.
- Change in Cash for Q1 2026 came in at $44.3 million, up 30053.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $174.4 million (up 307.04% YoY), and the FY2025 annual result was $130.2 million, up 187.07% from the prior year.
- Change in Cash came in at $44.3 million for Q1 2026 at Biohaven, roughly flat from $44.4 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $191.2 million in Q4 2022 to a low of -$154.3 million in Q3 2024.
- The 5-year median for Change in Cash is $14.5 million (2024), against an average of $11.8 million.
- Across the five-year window, Change in Cash slumped 376.63% in 2023 and surged 30053.74% in 2026, its largest moves.
- Biohaven's Change in Cash stood at $191.2 million in 2022, then plunged by 34.03% to $126.1 million in 2023, then tumbled by 88.49% to $14.5 million in 2024, then soared by 205.69% to $44.4 million in 2025, then fell by 0.16% to $44.3 million in 2026.
- The last three Change in Cash figures came in at $44.3 million (Q1 2026), $44.4 million (Q4 2025), and $19.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -45.97 Mn |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - | 44.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.33 Mn |
| Dec 31, 2025 | 44.40 Mn |
| Sep 30, 2025 | 19.39 Mn |
| Jun 30, 2025 | 66.31 Mn |
| Mar 31, 2025 | 147,000.00 |
| Dec 31, 2024 | 14.52 Mn |
| Sep 30, 2024 | -154.30 Mn |
| Jun 30, 2024 | 55.39 Mn |
| Mar 31, 2024 | -65.19 Mn |
| Dec 31, 2023 | 126.13 Mn |
| Sep 30, 2023 | -75.96 Mn |
| Jun 30, 2023 | 11.36 Mn |
| Mar 31, 2023 | -52.01 Mn |
| Dec 31, 2022 | 191.19 Mn |
| Sep 30, 2022 | 27.46 Mn |
| Jun 30, 2022 | -17.05 Mn |
| Mar 31, 2022 | -36.05 Mn |
| Dec 31, 2021 | -285.64 Mn |